Gateway 2012: Fluid Metering, Inc. - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Gateway 2012: Fluid Metering, Inc.

Fluid Metering, Inc.
5 Aerial Way, Suite 500
Syosset, NY  11791 USA

Fax: 516-624-8261

Fluid Metering, Inc. (FMI) manufactures unique, patented, valveless piston metering pumps and dispensers. With one moving part, a rotating and reciprocating ceramic piston, these pumps accomplish both pumping and valving functions. Flow rates range from 2.5 µl/dispense to flows of 4,600 ml/min with pressures to 200 psig. FMI pumps will dispense and meter fluids for millions of cycles with a drift free accuracy of better than 1%. Typical applications include fluid metering, dispensing and sampling for chemical process, laboratory, pilot plant, food processing, water treatment, and environmental analyzers.

Come Visit Us at Interphex – Booth #1576

Fluid Metering, Inc. will be exhibiting its line of Metering Pumps and Dispensers which are ideal for Pharmaceutical Processing applications. Contact us and arrange a meeting to discuss any current applications that we may help you with.


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns

Click here